To determine whether expression of TYRO3 and/or AXL was associated with PI3K inhibitor sensitivity at baseline (without prolonged drug exposure), we examined the protein expression of both receptors in a panel of 25 HNSCC cell lines (Additional Table 1) [20]. Here, AXL is linked to head and neck squamous cell carcinoma.